To study the effect a drug called Clonodine has on spinal anesthesia
Phase 3
- Conditions
- Health Condition 1: null- Patients admitted for lower abdomen and lower limb surgeries
- Registration Number
- CTRI/2017/08/009400
- Lead Sponsor
- Self
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients belonging to ASA I and ASA II class undergoing lower abdominal and lower limb surgeries
Exclusion Criteria
1)History or evidence of coagulopathy and bleeding disorders.
2 )Renal dysfunction
3 )Current use of antiplatelet medication and anticoagulants
4)Any localised infections at the site for spinal anesthesia
5) History of malignancy or coronary artery disease
6)Thromboembolic event and
7)Patient refusal
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect oral <br/ ><br>Clonodine premedication on Spinal Anesthesia using <br/ ><br>LevobupivacaineTimepoint: From the time of Anaesthesia till the time of complete recovery
- Secondary Outcome Measures
Name Time Method ) Evaluate the effect <br/ ><br> <br/ ><br>1) Evaluate the effect of oral clonidine premedication <br/ ><br> <br/ ><br>2) Compare the combined effect of oral clonidine and levobupivacaine on spinal anes-thesia versus levobupivacaine alone. <br/ ><br> <br/ ><br>3)To study the possible adverse effects of oral clonidine. <br/ ><br> <br/ ><br>Timepoint: 24 hours